- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05885087
'Extended Balloon Catheter' Labour Induction; a Single Arm Pilot Trial'
'Extended Balloon Catheter' Labour Induction; a Single Arm Pilot Trial
The overall aim of the single arm pilot study was to assess the effectiveness, safety and acceptance of the 'extended balloon catheter' as a method of induction of labour in women receiving care at Princess Marina Hospital(PMH) in Gaborone, Botswana.
The main questions it aimed to answer were whether 'extended balloon catheter' is an effective method of labour induction, whether it results in increased adverse events for the mother and baby and whether it is associated with increased mother satisfaction.
Participants were assessed as having a favourable cervix using the modified Bishop score of equal to or more than 7. Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied. Delivery interval (time of induction to time of delivery), mode of delivery and Apgar scores were recorded. Adverse maternal and neonatal outcomes were recorded. Participants' satisfaction with the method of induction was assessed using a descriptive scale.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Labour induction is indicated when the benefits to the mother and/or foetus of discontinuing the pregnancy outweigh the risks of awaiting spontaneous onset of labour. However, induction of labour is not without risk and the World Health Organisation recommends induction of labour be performed with a clear medical indication and when the expected benefits outweigh potential harms. Established indications for induction of labour include gestational age of 41 completed weeks or more, prelabour rupture of amniotic membranes, hypertensive disorders, maternal medical complications, foetal growth restriction, chorioamnionitis, multiple pregnancy, vaginal bleeding and other complications.
The ideal method for induction should be safe for both the mother and baby, cost effective and not require extensive monitoring. Trans-cervical extra-amniotic Foley catheter placement has been shown to be the safest method of labour induction with fewer maternal and neonatal side effects such as uterine hyperstimulation and changes in foetal heart rate during labour than prostaglandins or oxytocin. It has also been shown that there were no significant differences between caesarean and vaginal deliveries between Foley catheter, prostaglandins and oxytocin, although labour was shown to last longer after induction with Foley catheter than with prostaglandins and oxytocin. These factors can therefore potentially influence the women's preference for either method.
Foley catheter has generally been used for labour induction with an unfavourable cervix and once the cervix is favourable or the Foley method is unsuccessful, prostaglandins or oxytocin with amniotomy are used. In lower and middle income countries like Botswana where patient monitoring during induction of labour and labour is limited and mostly intermittent, mainly due to the limited or lack of monitoring devices to detect uterine hyperstimulation or foetal heart rate changes, a high patient to midwife ratio, and a high HIV prevalence, it may be preferable to avoid amniotomy and risks associated with hyperstimulation with exogenous oxytocin or prostaglandins. There are no randomized trials of Foley catheter induction with a favourable cervix reported in the Cochrane review of mechanical methods of labour induction. To optimize the likelihood of delivery without recourse to amniotomy and oxytocin or prostaglandins, 'extended balloon catheter' has been proposed as a method of continuing induction and augmentation with a Foley catheter rather than switching to other methods.
The purpose of this proposed single arm pilot trial was to test this novel idea of using 'extended balloon catheter' for induction of labour in women with favourable cervix in Botswana, and assess its effectiveness, safety to both the mother and baby as well as patient satisfaction with the procedure. Findings from this study will guide clinical protocols on how to utilize the safest available option for optimal maternal and neonatal outcomes as well as offer options and evidence for counselling women for whom prostaglandins or oxytocin are contraindicated or for use with caution in Botswana and elsewhere.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South East
-
Gaborone, South East, Botswana, 267
- Princess Marina Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women 18 years or older without serious morbidity due for labour induction, who give consent to participate.
- Cervix considered too far dilated to retain a single balloon, or single balloon has fallen out while not yet in labour.
- Bishop score of equal or more than 7.
- Nulliparous and multiparous
- Singleton and cephalic
- Gestation >37+0 weeks
- Estimated fetal weight <4kg
Exclusion Criteria:
- Previous caesarean delivery
- Very urgent labour induction indications (eg eclampsia, preeclampsia with severe features)
- Ruptured membranes
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Foley/Balloon catheter arm
Participants were assessed as having a favourable cervix using the modified Bishop score of equal to or more than 7. Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied.
|
Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Successful labor induction
Time Frame: Enrolment until 60 hours
|
Successful labor induction defined as vaginal birth within 60 hours.
|
Enrolment until 60 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse event
Time Frame: Enrolment until discharge from hospital, or up to 2 weeks
|
Any adverse maternal and fetal outcomes in participants
|
Enrolment until discharge from hospital, or up to 2 weeks
|
Acceptability
Time Frame: Enrolment until discharge from hospital, or up to 2 weeks
|
Satisfaction with the procedure as defined by postpartum questionnaire
|
Enrolment until discharge from hospital, or up to 2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: JUSTUS HOFMEYR, DSc, University of Botswana
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UBR/RES/IRB/BIO/GRAD/145
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor, Induced
-
Alexandra Hospital, Athens, GreeceNational and Kapodistrian University of AthensCompletedLabor, Induced | Induced; BirthGreece
-
University Hospital, GenevaQIAGEN Gaithersburg, Inc; Hologic, Inc.; Pregnolia ACCompletedLabor Onset | Labor, Induced | Labor, Obstetric | Predictive ModelSwitzerland
-
Oslo Metropolitan UniversityVestre Viken Hospital Trust; Oslo University HospitalCompletedLabor, Induced | Induced; BirthNorway
-
Chelsea and Westminster NHS Foundation TrustRecruiting
-
Oihane Lapuente OcamicaUnknown
-
Instituto Materno Infantil Prof. Fernando FigueiraUniversidade Federal do Ceará; Instituto de Saúde Elpidio de AlmeidaCompleted
-
Jena University HospitalCompleted
-
Professor Fernando Figueira Integral Medicine InstituteMaternidade Escola Assis ChateaubriandCompleted
-
Woman's Health University Hospital, EgyptUnknown
-
The University of Texas Health Science Center,...Completed
Clinical Trials on Foley or balloon catheter
-
The University of Texas Medical Branch, GalvestonActive, not recruitingLabor Induction | Early AmniotomyUnited States
-
Wake Forest University Health SciencesCompletedInduction of Labor Affected Fetus / NewbornUnited States
-
Beijing Obstetrics and Gynecology HospitalUnknownIntrauterine AdhesionChina
-
Western Galilee Hospital-NahariyaCompletedCesarean | Endometritis | Induction of LaborIsrael
-
Ministry of Health, SingaporeNational University Hospital, Singapore; National University of Singapore; Department... and other collaboratorsUnknownPregnancy Related | Labor Complication | Cesarean Section; DehiscenceSingapore
-
Haukeland University HospitalCompletedInduction of BirthNorway
-
Bactiguard ABRehab Station StockholmCompletedComplications; Catheter, Urinary Infection or InflammationSweden
-
Wenzhou Medical UniversityCompleted
-
Fundació Institut de Recerca de l'Hospital de la...European Clinical Research Infrastructure Network; Asociacion Colaboracion...TerminatedUrinary Tract InfectionSpain, Portugal, Chile, Italy, Turkey
-
Zeynep Kamil Maternity and Pediatric Research and...UnknownInduction of Labor Affected Fetus / Newborn | Preterm Premature Rupture of Fetal MembranesTurkey